Table 3 Predictors at enrollment of a suboptimal HRQoL at the 36-month follow-up

Age^a

1.01 (0.97–1.05)

1.02 (0.97–1.07)

1.06 (1.02–1.11)**

1.04 (0.99–1.09)

Sex^b

1.01 (0.70–1.45)

0.57 (0.38–0.85)**

SES score

0.97 (0.92–1.03)

Time between symptom onset and diagnosis

1.01 (1.00–1.03)

Uveitis

0.86 (0.41–1.66)

  Persistent oligoarthritis

Referent

  Extended oligoarthritis

1.58 (0.91–2.71)

  RF-negative polyarthritis

1.10 (0.69–1.73)

  RF-positive polyarthritis

2.24 (0.63–7.22)

  Psoriatic arthritis

1.53 (0.66–3.36)

  Enthesitis-related arthritis

0.95 (0.48–1.80)

  Systemic-onset JIA

1.22 (0.42–3.12)

  Undifferentiated arthritis

0.80 (0.34–1.71)

 cJADAS-10

1.03 (1.00–1.06)*

 PGA

1.02 (0.96–1.09)

 Parent’s global

1.19 (1.10–1.29)***

1.15 (1.05–1.26)**

1.14 (1.03–1.26)**

 Active joint count

1.00 (0.97–1.02)

 Numeric rating scale

1.14 (1.07–1.22)***

1.21 (1.13–1.30)***

 CHAQ

1.74 (1.36–2.23)***

 FaBel total

4.82 (2.96–7.98)***

3.88 (2.27– 6.72)***

2.97 (1.78–5.02)***

3.63 (2.04–6.53)***